EXRO TECHNOLOGIES INC (EXRO.CA) Fundamental Analysis & Valuation

TSX:EXRO • CA30222R1091

Current stock price

0.02 CAD
0 (0%)
Last:

This EXRO.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EXRO.CA Profitability Analysis

1.1 Basic Checks

  • In the past year EXRO has reported negative net income.
  • In the past year EXRO has reported a negative cash flow from operations.
  • In the past 5 years EXRO always reported negative net income.
  • In the past 5 years EXRO always reported negative operating cash flow.
EXRO.CA Yearly Net Income VS EBIT VS OCF VS FCFEXRO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -393.41%, EXRO is doing worse than 87.50% of the companies in the same industry.
Industry RankSector Rank
ROA -393.41%
ROE N/A
ROIC N/A
ROA(3y)-104.76%
ROA(5y)-77.92%
ROE(3y)-507.54%
ROE(5y)-322.11%
ROIC(3y)N/A
ROIC(5y)N/A
EXRO.CA Yearly ROA, ROE, ROICEXRO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EXRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EXRO.CA Yearly Profit, Operating, Gross MarginsEXRO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

0

2. EXRO.CA Health Analysis

2.1 Basic Checks

  • EXRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EXRO has more shares outstanding than it did 1 year ago.
  • EXRO has more shares outstanding than it did 5 years ago.
  • EXRO has a worse debt/assets ratio than last year.
EXRO.CA Yearly Shares OutstandingEXRO.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
EXRO.CA Yearly Total Debt VS Total AssetsEXRO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • EXRO has an Altman-Z score of -12.04. This is a bad value and indicates that EXRO is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -12.04, EXRO is doing worse than 68.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.04
ROIC/WACCN/A
WACC4.27%
EXRO.CA Yearly LT Debt VS Equity VS FCFEXRO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 0.51 indicates that EXRO may have some problems paying its short term obligations.
  • EXRO has a Current ratio of 0.51. This is in the lower half of the industry: EXRO underperforms 62.50% of its industry peers.
  • A Quick Ratio of 0.20 indicates that EXRO may have some problems paying its short term obligations.
  • EXRO has a Quick ratio of 0.20. This is amonst the worse of the industry: EXRO underperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.2
EXRO.CA Yearly Current Assets VS Current LiabilitesEXRO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

4

3. EXRO.CA Growth Analysis

3.1 Past

  • EXRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -140.00%.
  • Looking at the last year, EXRO shows a very strong growth in Revenue. The Revenue has grown by 201.09%.
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)201.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-44.9%

3.2 Future

  • EXRO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.83% yearly.
  • The Revenue is expected to grow by 114.52% on average over the next years. This is a very strong growth
EPS Next Y64.89%
EPS Next 2Y37.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-46.55%
Revenue Next 2Y50.17%
Revenue Next 3Y114.52%
Revenue Next 5YN/A

3.3 Evolution

EXRO.CA Yearly Revenue VS EstimatesEXRO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
EXRO.CA Yearly EPS VS EstimatesEXRO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

1

4. EXRO.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • EXRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year EXRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EXRO.CA Price Earnings VS Forward Price EarningsEXRO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EXRO.CA Per share dataEXRO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EXRO's earnings are expected to grow with 37.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.83%
EPS Next 3YN/A

0

5. EXRO.CA Dividend Analysis

5.1 Amount

  • No dividends for EXRO!.
Industry RankSector Rank
Dividend Yield N/A

EXRO.CA Fundamentals: All Metrics, Ratios and Statistics

EXRO TECHNOLOGIES INC

TSX:EXRO (9/17/2025, 7:00:00 PM)

0.02

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-14
Earnings (Next)11-11
Inst Owners18.04%
Inst Owner ChangeN/A
Ins Owners12.52%
Ins Owner ChangeN/A
Market Cap11.46M
Revenue(TTM)25.06M
Net Income(TTM)-353.31M
Analysts40
Price Target0.12 (500%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-282.82%
Min EPS beat(2)-553.59%
Max EPS beat(2)-12.04%
EPS beat(4)0
Avg EPS beat(4)-347.34%
Min EPS beat(4)-796.95%
Max EPS beat(4)-12.04%
EPS beat(8)3
Avg EPS beat(8)-180.49%
EPS beat(12)5
Avg EPS beat(12)-120.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-53.34%
Min Revenue beat(2)-58.74%
Max Revenue beat(2)-47.95%
Revenue beat(4)0
Avg Revenue beat(4)-45.37%
Min Revenue beat(4)-58.74%
Max Revenue beat(4)-37.05%
Revenue beat(8)0
Avg Revenue beat(8)-47.15%
Revenue beat(12)3
Avg Revenue beat(12)117.28%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-22.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.93%
EPS NY rev (1m)0%
EPS NY rev (3m)-103.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-86.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-69.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.72
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.04
BVpS-0.13
TBVpS-0.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -393.41%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-104.76%
ROA(5y)-77.92%
ROE(3y)-507.54%
ROE(5y)-322.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.89%
Cap/Sales 3.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.2
Altman-Z -12.04
F-Score3
WACC4.27%
ROIC/WACCN/A
Cap/Depr(3y)244.82%
Cap/Depr(5y)539.1%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y64.89%
EPS Next 2Y37.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)201.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-44.9%
Revenue Next Year-46.55%
Revenue Next 2Y50.17%
Revenue Next 3Y114.52%
Revenue Next 5YN/A
EBIT growth 1Y-48.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year78.86%
EBIT Next 3Y26.22%
EBIT Next 5YN/A
FCF growth 1Y-28.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.77%
OCF growth 3YN/A
OCF growth 5YN/A

EXRO TECHNOLOGIES INC / EXRO.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EXRO TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 1 / 10 to EXRO.CA.


What is the valuation status for EXRO stock?

ChartMill assigns a valuation rating of 1 / 10 to EXRO TECHNOLOGIES INC (EXRO.CA). This can be considered as Overvalued.


Can you provide the profitability details for EXRO TECHNOLOGIES INC?

EXRO TECHNOLOGIES INC (EXRO.CA) has a profitability rating of 0 / 10.


What is the financial health of EXRO TECHNOLOGIES INC (EXRO.CA) stock?

The financial health rating of EXRO TECHNOLOGIES INC (EXRO.CA) is 0 / 10.